Malaria diagnosis for malaria elimination

Current Opinion in Infectious Diseases

Volumn 28, Issue 5, 2015, Pages 446-454

  Zimmerman, Peter A ^a   Howes, Rosalind E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diagnosis; elimination; limits of detection; malaria

Indexed keywords

ANTIBODY; ANTIGEN; HEMOZOIN; NUCLEIC ACID; PARASITE PROTEIN; PARASITE SPECIFIC HUMAN ANTIBODY; PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BASED RAPID DIAGNOSTIC TEST; BLOOD SMEAR; CELLS; CONVENTIONAL BLOOD SMEAR MICROSCOPY; CYTOMETRY; DIAGNOSTIC TEST; DISEASE ELIMINATION; GEOGRAPHY; HUMAN; LIFE CYCLE; LIMIT OF DETECTION; MALARIA; MICROSCOPY; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION TEST; PARASITE CONTAINING CELL; REVIEW; ZOONOSIS; MOLECULAR DIAGNOSIS; PARASITOLOGY; PROCEDURES;

HUMANS; LIMIT OF DETECTION; MALARIA; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84949423352     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000191     Document Type: Review

References (90)

1. Oguike MC, Sutherland CJ. Dimorphism in genes encoding sexual-stage proteins of Plasmodium ovale curtisi and Plasmodium ovale wallikeri. Int J Parasitol. 2015; 45: 449-454.
2. Cox-Singh J. Zoonotic malaria: Plasmodium knowlesi, an emerging pathogen. Curr Opin Infect Dis. 2012; 25: 530-536.
3. Sandeu MM, Moussiliou A, Moiroux N, et al. Optimized Pan-species and speciation duplex real-Time PCR assays for Plasmodium parasites detection in malaria vectors. PLoS ONE. 2012; 7: e52719.
4. Wirtz RA, Zavala F, Charoenvit Y, et al. Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ. 1987; 65: 39-45.
5. Ramasamy R. Zoonotic malaria global overview and research and policy needs. Front Public Health. 2014; 2: 123.
6. Domingo GJ, Satyagraha AW, Anvikar A, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013; 12: 391.
7. Satyagraha AW, Sadhewa A, Baramuli V, et al. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria. PLoS Negl Trop Dis. 2015; 9: e0003602.
8. Roll Back Malaria Partnership (RBMP). The Global Malaria Action Plan for a Malaria-Free World. Geneva: World Health Organization; 2008.
9. Smith DL, Cohen JM, Moonen B, et al. Infectious disease. Solving the Sisyphean problem of malaria in Zanzibar. Science. 2011; 332: 1384-1385.
10. World Health Organization. World Malaria Report 2014. Geneva: World Health Organization; 2014. p. 242.
11. Alonso PL, Brown G, Arevalo-Herrera M, et al. A research agenda to underpin malaria eradication. PLoS Med. 2011; 8: e1000406.
12. Pampana EJ. A textbook of malaria eradication. London: Oxford University Press; 1969. p. 360.
13. World Health Organization. From malaria control to malaria elimination: a manual for elimination scenario planning: World Health Organization; 2014.
14. Bousema T, Okell L, Felger I, et al. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Miocrobiol. 2014; 12: 833-840.
15. Okell LC, Bousema T, Griffin JT, et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012; 3: 1237.
16. Tietje K, Hawkins K, Clerk C, et al. The essential role of infection-detection technologies for malaria elimination and eradication. Trends Parasitol. 2014; 30: 259-266.
17. Hawkins K, Burton R, LaBarre P, editors. Diagnostics to support malaria elimination: choosing an appropriate biomarker to target the subclinical Plasmodium falciparum transmission reservoir. Proceedings of IEEE 2014 Global Humanitarian Technology Conference; 10-13 October. 2014; San Jose, CA: IEEE; 2014.
18. Cheng Q, Cunningham J, Gatton ML. Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors. PLoS Negl Trop Dis. 2015; 9: e3413.
19. Cottrell G, Moussiliou A, Luty AJ, et al. Submicroscopic Plasmodium falciparum infections are associated with maternal anemia premature births, and low birth weight. Clin Infect Dis. 2015; 60: 1481-1488.
20. Isozumi R, Fukui M, Kaneko A, et al. Improved detection of malaria cases in island settings of Vanuatu and Kenya by PCR that targets the Plasmodium mitochondrial cytochrome c oxidase III (cox3) gene. Parasitol Int. 2015; 64: 304-308.
21. Lo E, Zhou G, Oo W, et al. Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya. PLoS ONE. 2015; 10: e0121763.
22. Morris U, Xu W, Msellem MI, et al. Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013. Infect Genet Evol. 2015; 33: 110-117.
23. SemaM, Alemu A, Bayih AG, et al. Evaluation of noninstrumented nucleic acid amplification by loop-mediated isothermal amplification (NINA-LAMP) for the diagnosis of malaria in Northwest Ethiopia. Malar J. 2015; 14: 44.
24. Talha AA, Pirahmadi S, Mehrizi AA, et al. Molecular genetic analysis of Plasmodium vivax isolates from Eastern and Central Sudan using pvcsp and pvmsp-3alpha genes as molecular markers. Infect Genet Evol. 2015; 32: 12-22.
25. Ehtesham R, Heidari A, Raeisi A, et al. Detection of mixed-species infections of Plasmodium falciparum and Plasmodium vivax by nested PCR and rapid diagnostic tests in southeastern Iran. Am J Trop Med Hyg 2015.
26. Baum E, Sattabongkot J, Sirichaisinthop J, et al. Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand: molecular and serological evidence. Malar J. 2015; 14: 95.
27. Chaturvedi N, Bhandari S, Bharti PK, et al. Sympatric distribution of Plasmodium ovale curtisi and P. ovale wallikeri in India: implication for the diagnosis of malaria and its control. Trans R Soc Trop Med Hyg. 2015; 109: 352-354.
28. Waltmann A, Darcy AW, Harris I, et al. High rates of asymptomatic, submicroscopic Plasmodium vivax infection and disappearing Plasmodium falciparum malaria in an area of low transmission in Solomon Islands. PLoS Negl Trop Dis. 2015; 9: e0003758.
29. Thanh PV, Hong NV, Van Van N, et al. Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir. Malar J. 2015; 14: 86.
30. Cheng Z, Wang D, Tian X, et al. Capture and ligation probe-PCR (CLIP-PCR) for molecular screening, with application to active malaria surveillance for elimination. Clin Chem. 2015; 61: 821-828.
31. Vallejo AF, Chaparro PE, Benavides Y, et al. High prevalence of sub-microscopic infections in Colombia. Malar J. 2015; 14: 201.
32. Dacremont V, Kahama-Maro J, Swai N, et al. Reduction of antimalarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-After and cluster randomized controlled study. Malar J. 2011; 10: 107.
33. Karl S, Gurarie D, Zimmerman PA, et al. A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS ONE. 2011; 6: e20805.
34. Moore LR, Fujioka H, Williams PS, et al. Hemoglobin degradation in malariainfected erythrocytes determined from live cell magnetophoresis. Faseb J. 2006; 20: 747-749.
35. Gravenor MB, van Hensbroek MB, Kwiatkowski D. Estimating sequestered parasite population dynamics in cerebral malaria. Proc Natl Acad Sci U S A. 1998; 95: 7620-7624.
36. Lee KS, Cox-Singh J, Singh B. Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. Malar J. 2009; 8: 73.
37. Antinori S, Galimberti L, Milazzo L, et al. Biology of human malaria plasmodia including Plasmodium knowlesi. Mediterr J Hematol Infect Dis. 2012; 4: e2012013.
38. Kerlin DH, Gatton ML. Preferential invasion by Plasmodium merozoites and the self-regulation of parasite burden. PLoS ONE. 2013; 8: e57434.
39. Gething PW, Elyazar IR, Moyes CL, et al. A long neglected world malaria map: Plasmodium vivax endemicity in. PLoS Negl Trop Dis. 2012; 6: e1814.
40. Gething PW, Patil AP, Smith DL, et al. A new world malaria map: Plasmodium falciparum endemicity in. Malar J. 2011; 10: 378.
41. Moyes CL, Henry AJ, Golding N, et al. Defining the geographical range of the Plasmodium knowlesi reservoir. PLoS Negl Trop Dis. 2014; 8: e2780.
42. Muller M, Schlagenhauf P. Plasmodium knowlesi in travellers, update. Int J Infect Dis. 2014; 22: 55-64.
43. Alonso PL, Bassat Q, Binka F, et al. A research agenda for malaria eradication: drugs. PLoS Med. 2011; 8: e1000402.
44. World Health Organization. Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings (version 1.0): procedure: methods manual.: World Health Organization; 2015. p. 32.
45. Dowling MA, Shute GT. A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia. Bull World Health Organ. 1966; 34: 249-267.
46. Maguire JD, Lederman ER, Barcus MJ, et al. Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency. Malar J. 2006; 5: 92.
47. Zimmerman PA, Thomson JM, Fujioka H, et al. Diagnosis of malaria by magnetic deposition microscopy. Am J Trop Med Hyg. 2006; 74: 568-572.
48. Karl S, David M, Moore L, et al. Enhanced detection of gametocytes by magnetic deposition microscopy predicts higher potential for Plasmodium falciparum transmission. Malar J. 2008; 7: 66.
49. Kremsner PG, Valim C, Missinou MA, et al. Prognostic value of circulating pigmented cells in African children with malaria. J Infect Dis. 2009; 199: 142-150.
50. Metzger WG, Mordmuller BG, Kremsner PG. Malaria pigment in leucocytes. Trans R Soc Trop Med Hyg. 1995; 89: 637-638.
51. Campo JJ, Aponte JJ, Nhabomba AJ, et al. Feasibility of flow cytometry for measurements of Plasmodium falciparum parasite burden in studies in areas of malaria endemicity by use of bidimensional assessment of YOYO-1 and autofluorescence. J Clin Microbiol. 2011; 49: 968-974.
52. Jagannadh VK, Murthy RS, Srinivasan R, et al. Automated quantitative cytological analysis using portable microfluidic microscopy. J Biophotonics 2015. [Epub ahead of print
53. Malleret B, Claser C, Ong AS, et al. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep. 2011; 1: 118.
54. Rebelo M, Tempera C, Bispo C, et al. Light depolarization measurements in malaria: a new job for an old friend. Cytometry A. 2015; 87: 437-445.
55. Shapiro HM, Apte SH, Chojnowski GM, et al. Cytometry in malaria: a practical replacement for microscopy?. Current protocols in cytometry/editorial board, J Paul Robinson, managing editor [et al]. 2013; Chapter 11: Unit 11 20.
56. World Health Organization. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 5 (2013). Geneva: World Health Organization; 2014. p. 130.
57. Gillet P, Mumba Ngoyi D, Lukuka A, et al. False positivity of nontargeted infections in malaria rapid diagnostic tests: the case of human african trypanosomiasis. PLoS Negl Trop Dis. 2013; 7: e2180.
58. Leshem E, Keller N, Guthman D, et al. False-positive Plasmodium falciparum histidine-rich protein 2 immunocapture assay results for acute schistosomiasis caused by Schistosoma mekongi. J Clin Microbiol. 2011; 49: 2331-2332.
59. Gamboa D, Ho MF, Bendezu J, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE. 2010; 5: e8091.
60. Cheng Q, Gatton ML, Barnwell J, et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J. 2014; 13: 283.
61. Udhayakumar V, Barnwell J. Molecular profile and survey of hrp2 and hrp3 genetic deletions in South America. Amazon Malaria Initiative (AMI)/Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA) Annual Meeting; Lima, Peru; 9 April 2013.
62. Erdman LK, Kain KC. Molecular diagnostic and surveillance tools for global malaria control. Travel Med Infect Dis. 2008; 6 (1-2): 82-99.
63. Cordray MS, Richards-Kortum RR. Emerging nucleic acid-based tests for point-of-care detection of malaria. Am J Trop Med Hyg. 2012; 87: 223-230.
64. World Health Organization. WHO Evidence Review Group on Malaria Diagnosis in Low Transmission Settings. In: Meeting, M.P.A.C., editor. Geneva: World Health Organization; 2014. p. 33.
65. Okell LC, Ghani AC, Lyons E, et al. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-Analysis. J Infect Dis. 2009; 200: 1509-1517.
66. Greenwood B. The molecular epidemiology of malaria. Trop Med Int Health. 2002; 7: 1012-1021.
67. Snounou G, Viriyakosol S, Jarra W, et al. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993; 58: 283-292.
68. McNamara DT, Kasehagen LJ, Grimberg BT, et al. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am J Trop Med Hyg. 2006; 74: 413-421.
69. Cheng Q, Cloonan N, Fischer K, et al. stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. Mol Biochem Parasitol. 1998; 97 (1-2): 161-176.
70. Steenkeste N, Incardona S, Chy S, et al. Towards high-Throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J. 2009; 8: 86.
71. Hofmann N, Mwingira F, Shekalaghe S, et al. Ultra-sensitive detection of Plasmodium falciparum by amplification of multicopy subtelomeric targets. PLoS Med. 2015; 12: e1001788.
72. Patel JC, Oberstaller J, Xayavong M, et al. Real-Time loop-mediated isothermal amplification (RealAmp) for the species-specific identification of Plasmodium vivax. PLoS ONE. 2013; 8: e54986.
73. Smits HL, Gussenhoven GC, Terpstra W, et al. Detection, identification and semi-quantification of malaria parasites by NASBA amplification of small subunit ribosomal RNA sequences. J Microbiol Methods. 1997; 28: 65-75.
74. Imwong M, Hanchana S, Malleret B, et al. High-Throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014; 52: 3303-3309.
75. Murphy SC, Hermsen CC, Douglas AD, et al. External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance. PLoS ONE. 2014; 9: e97398.
76. Taylor SM, Juliano JJ, Trottman PA, et al. High-Throughput pooling and realtime PCR-based strategy for malaria detection. J Clin Microbiol. 2010; 48: 512-519.
77. Hsiang MS, Hwang J, Kunene S, et al. Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS ONE. 2012; 7: e29550.
78. Hopkins H, Gonzalez IJ, Polley SD, et al. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loopmediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis. 2013; 208: 645-652.
79. Taylor BJ, Howell A, Martin KA, et al. A lab-on-chip for malaria diagnosis and surveillance. Malar J. 2014; 13: 179.
80. Butykai A, Orban A, Kocsis V, et al. Malaria pigment crystals as magnetic micro-rotors: key for high-sensitivity diagnosis. Sci Rep. 2013; 3: 1431.
81. Khoshmanesh A, Dixon MW, Kenny S, et al. Detection and quantification of early-stage malaria parasites in laboratory infected erythrocytes by attenuated total reflectance infrared spectroscopy and multivariate analysis. Anal Chem. 2014; 86: 4379-4386.
82. Mens PF, Matelon RJ, Nour BY, et al. Laboratory evaluation on the sensitivity and specificity of a novel and rapid detection method for malaria diagnosis based on magneto-optical technology (MOT). Malar J. 2010; 9: 207.
83. Newman DM, Heptinstall J, Matelon RJ, et al. A magneto-optic route toward the in vivo diagnosis of malaria: preliminary results and preclinical trial data. Biophys J. 2008; 95: 994-1000.
84. Orban A, Butykai A, Molnar A, et al. Evaluation of a novel magneto-optical method for the detection of malaria parasites. PLoS ONE. 2014; 9: e96981.
85. Peng WK, Kong TF, Ng CS, et al. Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis. Nat Med. 2014; 20: 1069-1073.
86. Yuen C, Liu Q. Magnetic field enriched surface enhanced resonance Raman spectroscopy for early malaria diagnosis. J Biomed Opt. 2012; 17: 017005.
87. Lukianova-Hleb EY, Campbell KM, Constantinou PE, et al. Hemozoin-generated vapor nanobubbles for transdermal reagent- And needle-free detection of malaria. Proc Natl Acad Sci U S A. 2014; 111: 900-905.
88. Lukianova-Hleb E, Bezek S, Szigeti R, et al. Transdermal diagnosis of malaria using vapor nanobubbles. Emerg Infect Dis. 2015; 21: 1122-1127.
89. Bustin SA, Benes V, Garson J, et al. The need for transparency and good practices in the qPCR literature. Nat Methods. 2013; 10: 1063-1067.
90. Dalrymple U, Mappin B, Gething PW. Malaria mapping: understanding the global endemicity of falciparum and vivax malaria. BMC Med. 2015; 13: 140.